EcoDrugPlus

Ribosomal Protein, Large, P1

Ensembl ID : ENSPMAG00000001314
Gene Symbol: RPLP1
1 Cross references
382 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSPMAG00000003194
Gene Symbol: SMO
1 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSPMAG00000007655
Gene Symbol: SCNN1A
2 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSPMAG00000009242
Gene Symbol: SCNN1B
2 Cross references
151 Possible Orthologues:

Solute Carrier Family 18 Member 2

Ensembl ID : ENSPMAG00000003132
Gene Symbol: SLC18A2
1 Cross references
224 Possible Orthologues:

Solute Carrier Family 5 Member 1

Ensembl ID : ENSPMAG00000005357
Gene Symbol: SLC5A1
1 Cross references
250 Possible Orthologues:

Solute Carrier Family 6 Member 1a

Ensembl ID : ENSPMAG00000002090
Gene Symbol: SLC6A1A
1 Cross references
278 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSPMAG00000002371
Gene Symbol: SLC9A3
1 Cross references
234 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSPMAG00000010125
Gene Symbol: SSTR1
2 Cross references
158 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSPMAG00000001787
Gene Symbol: SRD5A2A
1 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPMAG00000009365
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPMAG00000002462
Gene Symbol: TBXA2R
2 Cross references
304 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).